Authors
Latest:
Data Unleashed: Cooperation Among CompetitorsCharting two years of collaborative progress in clinical trial data sharing.
Latest:
Closing the Gaps in Drug Chain of CustodyLimitations of the Drug Supply Chain Security Act for pharma-and three strategies to fix them.
Latest:
Alphabet’s Health Care Laundry ListWhen an 800-pound gorilla stakes a claim in an industry sector, the incumbents sit up and take notice-particularly when the gorilla is named Alphabet and is the parent company of Google. Cassie Arnold reports.
Latest:
Who Will Win the Race to Treat NASH?The liver disease non-alcoholic steatohepatitis (NASH) has become a priority for the healthcare industry – and, potentially, a multi-billion-dollar market. The race is now to develop the first effective pharmacotherapy to treat it.
Latest:
Pharma’s Big Push for ValueAn “how to” primer for life sciences companies on applying end-to-end evidence strategies in demonstrating product value.
Latest:
Making the Most Out of Your Real EstateAs companies look to raise capital, selling and then leasing back real estate is a tempting option and one that other industries are utilizing, writes Karen Williamson.
Latest:
Registries and the Future of MedicinePayers, providers, patients and pharma companies all want to understand the value of specific treatments – and patient registries can help them do that.
Latest:
Real-time Data Tracking in the Clinical Trial Supply ChainGood Distribution Practice means that ‘track and trace’ is becoming indispensable for drug product integrity. Interactive Response Technologies may offer a potential solution.
Latest:
Brexit and the UK Pharma IndustryEleanor Biggs looks at the biggest uncertainties facing the pharma industry if the UK were to leave the EU.
Latest:
Investing in Patient-Centric Capabilities Requires a Clear StrategyFor those willing to invest in the right capabilities, offering patient services can give pharma companies a tremendous opportunity.
Latest:
Mining Cancer Kryptonite from Historic Clinical Trial DataClinical trial data from completed trials are now beginning to be shared through a variety of channels. While skeptics remain, evidence is growing that this data can lead to practice-changing behavior in patient care.
Latest:
A Digital Prescription for the Pharma IndustryHow companies can better integrate valuable data across business functions to meet rising value-chain demands.
Latest:
A Digital Prescription for the Pharma IndustryHow companies can better integrate valuable data across business functions to meet rising value-chain demands.
Latest:
A Digital Prescription for the Pharma IndustryHow companies can better integrate valuable data across business functions to meet rising value-chain demands.
Latest:
A Digital Prescription for the Pharma IndustryHow companies can better integrate valuable data across business functions to meet rising value-chain demands.
Latest:
A New Era for Market Access: Organizing the Function’s Broader Strategic RoleBCG’s 2022 benchmark study uncovers new competencies needed for pharma access leaders in enterprise-wide business strategy, where thoughtfully designed approaches and goals focused on shared priority and responsibility are increasingly important.
Latest:
Measuring Pharma’s Trust PerformanceThe core building blocks of trust must be operationalized for pharma companies to strengthen their social contract, deliver business value, and improve patients’ quality of life.
Latest:
What is Required of Drug Safety During the COVID-19 PandemicIt is essential to ensure the safety profiles of potential COVID-19 therapies are supported by robust data so that healthcare providers and physicians can make appropriate, evidence-based decisions, writes Dr. Andrew Rut.
Latest:
'PRIME' Time for Medicines in the EUA look at how Europe's new accelerated drug approval scheme can evolve existing review pathways for the better-and take a page from FDA
Latest:
Tackling the Trust IssuePharma's challenge is to break the cycle of mistrust so that its pioneering work can fully reach patients in need, writes GSK's Murray Stewart.
Latest:
Swerving the Talent TrapHighly skilled pharma staff are obliged to devote hours to routine administrative tasks updating product information. Technology can free them from this burden, writes Dr. Jutta Hohenhörst.
Latest:
Realizing the Potential of Asia-PacificCompanies that want to tap into the full potential of Asia-Pac must boost the role of their regional headquarters.
Latest:
“Have We Met Your Needs Today?” Patient Centricity is So Much More than a Customer Satisfaction SurveyIn the healthcare industry, “patient centricity” is like comfort food – everyone knows what it is, but it can mean very different things to different people.
